NOVO NORDISK A/S

Connections Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 13/03/2026 GMT			5-day change	1st Jan Change
247.05 ^DKK	+0.02%		-0.34%	-24.04%

03-14	How are different indices influenced?
03-13	Form Health Joins Lilly Employer Connect Platform	CI

48

Listed companies

50

Private companies

310

Insiders

Relation chart of related listed companies: Novo Nordisk A/S

Active Relations

Past Relations

Related listed companies: Novo Nordisk A/S

GERON CORPORATION

ANGLO AMERICAN PLC

H. LUNDBECK A/S

Kristine Færch

KERRY GROUP PLC

René Schneider

Carsten Hellmann

Nicolai Buhl Andersen

GN STORE NORD A/S

Anna Héléne Barnekow

Maziar Mike Doustdar

BAVARIAN NORDIC A/S

Britt Meelby Jensen

EMBLA MEDICAL HF.

ALK-ABELLÓ A/S

Anders Hedegaard

Jesper Høiland

ELGI EQUIPMENTS LIMITED

Srinivasan Ravindran

ENANTA PHARMACEUTICALS, INC.

SCIBASE HOLDING AB (PUBL)

Jesper Høiland

ZEALAND PHARMA A/S

Adam Sinding Steensberg

Henriette Wennicke

ASCENDIS PHARMA A/S

Lotte Sønderbjerg

Flemming Steen Jensen

SUNSHINE HOLDINGS PLC

Sanjeev Shishoo

VIBROSENSE DYNAMICS AB

Mozhgan Dorkhan

CELLDEX THERAPEUTICS, INC.

XSPRAY PHARMA AB

Camilla Sylvest

Christian Kanstrup

SWEDISH ORPHAN BIOVITRUM AB

Jesper Elsgaard

Göran Albert Ando

Jakob Dynnes Hansen

Julie Waras Brogren

STAYBLE THERAPEUTICS AB

Jane Buus Laursen

ASCELIA PHARMA AB

Julie Waras Brogren

Björn Oskar Larsson

PURE BIOLOGICS S.A.

PDS BIOTECHNOLOGY CORPORATION

Lars Robert Boesgaard

STRUCTURE THERAPEUTICS INC.

Rachel Curtis Gravesen

Flemming Steen Jensen

Christian Kanstrup

ACHILLES THERAPEUTICS PLC

ALLARITY THERAPEUTICS, INC.

Jesper Høiland

Susanne Hundsbæk-Pedersen

Active Relations

Past Relations

Relationship chart for related private companies: Novo Nordisk A/S

Active Relations

Past Relations

Related private companies: Novo Nordisk A/S

Novo Nordisk Pharma GmbH

Pharmaceuticals: Major

Camilla Sylvest

Novo Nordisk Fonden

Investment Trusts/Mutual Funds

Lars Rebien Sørensen

Mads Krogsgaard Thomsen

Steen Riisgaard

Novo Holdings A/S (Denmark)

Financial Conglomerates

Britt Meelby Jensen

Ferring Pharmaceuticals A/S

Pharmaceuticals: Major

Lars Rebien Sørensen

Mozhgan Dorkhan

William Demant Invest A/S

Investment Managers

Jesper Brandgaard

LEO Pharma A/S

Pharmaceuticals: Major

Peter Helt Jacobsen Haahr

Jesper Brandgaard

Bioneer A/S

Pharmaceuticals: Major

University of Copenhagen

Other Consumer Services

Thue Walter Schwartz

Kristine Færch

Hempel A/S

Industrial Specialties

Karsten Munk Knudsen

Britt Meelby Jensen

Forbion Capital Partners Management Holding BV

Investment Managers

Patrick Michael Round

European Federation of Pharmaceutical Industries & Assns

Miscellaneous Commercial Services

Martin Hermanus Soeters

Lars Fruergaard Jorgensen

Novo Nordisk, Inc.

Biotechnology

LEO Fondet

Biotechnology

Peter Helt Jacobsen Haahr

2cureX ApS

Pharmaceuticals: Major

RSP Systems A/S

Medical Specialties

Liselotte Hyveled

Danmark-Amerika Fondet

Helion Biotech ApS

Pharmaceuticals: Major

Per Bo Pedersen Fischer

Jeppe Vesti Christensen

Dansk Biotek

Miscellaneous Commercial Services

Britt Meelby Jensen

Leo Pharma, Inc.

Drugstore Chains

Peter Helt Jacobsen Haahr

Jesper Brandgaard

Pharmacosmos A/S

Biotechnology

Novo Nordisk Region Aameo & Latam A/S

Financial Conglomerates

Ole Falvig Ramsby

Karsten Munk Knudsen

Asarina Pharma AB

Pharmaceuticals: Major

Jakob Dynnes Hansen

Medicon Valley Alliance FMBA

Miscellaneous Commercial Services

Søren Bregenholt

Peter Jens Lindholm Kurtzhals

Steno Diabetes Center A/S

Martin Hermanus Soeters

Mads Krogsgaard Thomsen

Peter Jens Lindholm Kurtzhals

Dansk Erhverv

Miscellaneous Commercial Services

Carsten Hellmann

Aniona ApS

Medical/Nursing Services

Anker Gunvald Lundemose

Claus Tycho Bræstrup

Thomas Feldthus

Galecto Biotech ApS

Pharmaceuticals: Major

Anders Pedersen

Dorrit T. Andersen

Arts Biologics A/S

Novo Nordisk Haemophilia Foundation

Jesper Brandgaard

Christian Kanstrup

Ludovic Helfgott

Novo Nordisk Health Care AG

Pharmaceuticals: Major

Jesper Brandgaard

Maziar Mike Doustdar

New Xellia Group A/S

Financial Conglomerates

Steen Riisgaard

Per Toft Valstorp

CytoVac AS

Biotechnology

Peter Bonne Eriksen

Sonion Holdco A/S

Financial Conglomerates

Peter Helt Jacobsen Haahr

Nuvelution Pharma, Inc.

Biotechnology

Nouscom AG

Pharmaceuticals: Major

Göran Albert Ando

The Danish Business Authority

National Agency

Adam Sinding Steensberg

VækstPartner Kapital ApS

Investment Managers

Jesper Brandgaard

Klaus Bülow Davidsen

World Diabetes Foundation

Investment Trusts/Mutual Funds

Camilla Sylvest

Varmx BV

Biotechnology

Momentum Gruppen A/S

Electric Utilities

Novo Holdings A/S (Investment Company)

Financial Conglomerates

Lars Rebien Sørensen

LEO Holding A/S (Denmark)

Miscellaneous

Peter Helt Jacobsen Haahr

ResoTher Pharma AS

Pharmaceuticals: Major

Thomas Feldthus

Xellia Holdco A/S

Peter Helt Jacobsen Haahr

Novo Invest 1 A/S

Financial Conglomerates

Peter Helt Jacobsen Haahr

WDH Germany GmbH

Specialty Stores

René Schneider

Eir Ventures Partners AB

Investment Managers

Stephan Christgau

Nouscom Srl

Miscellaneous Commercial Services

Göran Albert Ando

Momentum Energy Group A/S

Electric Utilities

Enduro Genetics ApS

Miscellaneous Commercial Services

Thomas Videbaek

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Pharmaceuticals: Major	28
Medical Specialties	13
Biotechnology	13
Miscellaneous Commercial Services	6
Financial Conglomerates	6
Investment Managers	4
Electric Utilities	2
Investment Trusts/Mutual Funds	2
Medical/Nursing Services	2
Drugstore Chains	2

Countries of related companies

Denmark	53
Sweden	13
United States	10
Germany	4
Switzerland	3
Netherlands	3
United Kingdom	3
Belgium	2
Italy	1
Poland	1

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (93.7%); - rare disease treatment products (6.3%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe and Canada (21.4%), the United States (56%), Latin America/Middle East/Africa (9.9%), China/Hong Kong/Taiwan (6%), Asia/Pacific (6.7%).

Employees

69,150

Sector

Pharmaceuticals

Calendar

03-27 - Ex-dividend date - 7.95 DKK

More about the company

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!

BENEFIT NOW